Table 1.
Clinical and pathological characteristics for 506 EC patients..
| Characteristics | Number of patients(%) |
|---|---|
| Age | 55.76 ± 9.56 |
| <55 years | 220 (43.48) |
| ≥55 years | 286 (56.52) |
| Menopause | |
| Premenopausal status | 184 (36.40) |
| Postmenopausal status | 322 (63.60) |
| Histotype | |
| EEA | 436 (86.20) |
| SEA | 70 (13.80) |
| Grade | |
| 1 | 169 (33.40) |
| 2–3 | 337 (66.60) |
| Stage | |
| I | 402(79.40) |
| II–IV | 104 (20.60) |
| LNM | |
| Negative | 364 (71.9) |
| Positive | 56 (11.1) |
| NA | 86 (17) |
| LVSI | |
| Negative | 419 (82.8) |
| Positive | 87 (17.2) |
| MI | |
| Superficial | 337 (66.6) |
| Deep | 169 (33.4) |
| Ascites tumor | |
| Negative | 352 (69.6) |
| Positive | 35 (6.9) |
| NA | 119 (23.5) |
| MetS | |
| Without | 353 (69.80) |
| With | 153 (30.20) |
| MetS components | |
| 0 components | 73 (14.4) |
| 1–2 components | 280 (55.3) |
| ≥3 components | 153 (30.2) |
| Blood glucose | |
| Normal glycemia | 305 (60.30) |
| Hyperglycemia | 201 (39.70) |
| BMI | |
| <25 kg/m2 | 221 (43.70) |
| ≥25 kg/m2 | 285 (56.30) |
| Hypertension | |
| Without | 297 (58.70) |
| With | 209 (41.30) |
| Dyslipidemia | |
| Without | 255 (50.40) |
| With | 251 (49.60) |
| TG | |
| <1.69 mmol/l | 339 (67%) |
| ≥1.69 mmol/l | 167 (33%) |
| HDL-C | |
| ≥1.0 mmol/l | 369 (72.92%) |
| <1.0 mmol/l | 137 (27.08%) |